Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
66 studies found for:    "Pilocytic astrocytoma"
Show Display Options
Rank Status Study
21 Recruiting Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas
Condition: Brain Tumor, Recurrent
Intervention: Drug: Photofrin photodynamic therapy.
22 Recruiting Photodynamic Therapy (PDT) for Brain Tumors
Condition: Brain Tumor, Recurrent
Intervention: Drug: Photofrin (porfimer sodium) & photodynamic therapy.
23 Active, not recruiting Bevacizumab in Recurrent Grade II and III Glioma
Condition: Central Nervous System Tumors
Interventions: Biological: Bevacizumab;   Drug: Temozolomide
24 Completed Study of Blood and Cheek Cell Samples From Patients With Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: medical chart review
25 Completed Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: therapeutic autologous lymphocytes;   Genetic: gene expression analysis;   Other: laboratory biomarker analysis
26 Completed Temozolomide in Treating Patients With Progressive Low-Grade Glioma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: temozolomide
27 Completed Study of Tissue Samples From Patients With Glioma or Other Brain Tumors
Condition: Central Nervous System Lymphoma
Interventions: Other: laboratory biomarker analysis;   Other: pharmacogenomic studies
28 Active, not recruiting Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: everolimus;   Drug: temozolomide;   Radiation: radiation
29 Completed Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers
Condition: Stage IV Melanoma
Interventions: Biological: recombinant interferon alfa-2b;   Drug: cisplatin;   Drug: sodium stibogluconate;   Drug: dacarbazine;   Drug: vinblastine
30 Completed Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: chemotherapy;   Procedure: conventional surgery;   Procedure: magnetic resonance imaging;   Procedure: magnetic resonance spectroscopic imaging;   Radiation: radiation therapy
31 Active, not recruiting Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: lonafarnib;   Drug: temozolomide
32 Completed Imatinib Mesylate in Treating Patients With Gliomas
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: imatinib mesylate
33 Completed Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: gefitinib
34 Completed Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors
Conditions: Brain Tumors;   Nervous System Tumors;   Cognition Disorders;   Fatigue
Interventions: Drug: Armodafinil;   Other: placebo
35 Completed Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma
Conditions: Brain and Central Nervous System Tumors;   Infection
Interventions: Other: laboratory biomarker analysis;   Other: questionnaire administration
36 Completed Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment
Conditions: Brain and Central Nervous System Tumors;   Lymphoma;   Metastatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: bortezomib;   Drug: temozolomide;   Other: pharmacological study
37 Completed Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors
Conditions: Brain and Central Nervous System Tumors;   Metastatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: carboplatin;   Drug: tamoxifen citrate;   Drug: topotecan hydrochloride;   Other: pharmacological study
38 Completed
Has Results
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Condition: Cancer
Interventions: Drug: Fentanyl sublingual spray;   Drug: Placebo
39 Completed Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: Erlotinib + Sirolimus
40 Completed Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors
Conditions: Brain and Central Nervous System Tumors;   Chemotherapeutic Agent Toxicity;   Infertility
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.